Cargando…
Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity
Chronic hyperglycemia and the corresponding glucotoxicity are the main pathogenic mechanisms of diabetes and its complications. Streptozotocin (STZ)-induced diabetic animal models are useful platforms for the understanding of β cell glucotoxicity in diabetes. As diabetes induced by a single STZ inje...
Autores principales: | Wu, Jinzi, Yan, Liang-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396517/ https://www.ncbi.nlm.nih.gov/pubmed/25897251 http://dx.doi.org/10.2147/DMSO.S82272 |
Ejemplares similares
-
Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications
por: Zheng, Hong, et al.
Publicado: (2016) -
Antioxidative and Hypoglycemic Effect of Ta-ermi Extracts on Streptozotocin-Induced Diabetes
por: Jing, Siqun, et al.
Publicado: (2020) -
The Nicotinamide/Streptozotocin Rodent Model of Type 2 Diabetes: Renal Pathophysiology and Redox Imbalance Features
por: Yan, Liang-Jun
Publicado: (2022) -
The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity
por: Oelze, Matthias, et al.
Publicado: (2014) -
Streptozotocin-induced type 1 and 2 diabetes in rodents: a model for studying diabetic cardiac autonomic neuropathy
por: Akinlade, Olawale Mathias, et al.
Publicado: (2021)